VIB7734
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for VIB7734, covering 2024-07-23 to 2024-12-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis [Phase 1]